Closing out strong, join MSK radiation oncologist Dr. Amy Xu at #ASCO26 as she presents results from a phase II study evaluating genomically personalized radiation dose de-escalation in patients with pathogenic ATM mutations.
š Tuesday, June 2 | 10:39 a.m. CDT
Learn more: https://bit.ly/4x1m1ST
MSK scientists have uncovered a hidden role for RNA.
Researchers led by MSK molecular and cell biologist @christinemayr.bsky.social found that RNA can act as a critical regulatory proteins, revealing a previously unknown function of RNA. Learn more: https://bit.ly/3QpBprx
š Congrats to MSK's most recent awards & appointments, including Dr. Yelena Janjigian, Dr. Samuel Cytryn, and Dr. Jeremy Tchack for being awarded funding by the Torrey Coast Foundation; Dr. Scott Lowe for receiving the 2026 Lotus Award; and more: www.mskcc.org/news-release...
Join MSK medical oncologist Dr. Darren Feldman at #ASCO26 for an education session on optimizing treatment for patients with poor-risk testicular cancer, including a discussion on the management of brain metastasis.
š Monday, June 1 | 1:51 p.m. CDT
Learn more: https://bit.ly/4uEc3VN
Join MSK's Dr. Michael Morris at #ASCO26 as he presents results from CONVERGE-01 Part 3 evaluating Ac-225 rosopatamab tetraxetan in patients w/ metastatic castration-resistant #prostatecancer previously treated with Lu-PSMA therapy.
Learn more: meetings.asco.org/meetings/202...
Missed some of the research presented by MSK experts at #ASCO26?
We've rounded up selected highlights spanning sarcoma, liver cancer, lung cancer, prostate cancer, blood cancers, and more: https://bit.ly/3Qfyv8Q
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Join MSK thoracic medical oncologist Dr. Jamie Chaft at #ASCO26 as she presents results from the phase III ALCHEMIST trial evaluating nivolumab after surgery and adjuvant chemotherapy in patients with non-small cell lung cancer.
š Monday, June 1 | 1:15 p.m. CDT
Learn more: https://bit.ly/3Q9i1Pw
Memorial Sloan Kettering Cancer Center
Coming up at #ASCO26: Join #melanoma medical oncologist Dr. Alexander Shoushtari for a presentation on how new tumor-infiltrating lymphocyte research can be translated into real benefit for patients. @mskcancercenter.bsky.social
š Monday, June 1 | 5:30 p.m. CDT
Learn more: https://bit.ly/4nX5jjg
mRNA 3ā² UTRs chaperone intrinsically disordered regions to control protein activity @cellcellpress.bsky.social @mskcancercenter.bsky.social @christinemayr.bsky.social
www.cell.com/cell/fulltex...
š¢ New Review Published in EXO!
Title: Ferroptosis spreading through propagative signals
By Drs. Saloni K. Hombalkar, Jyotirekha Das, and Michael Overholtzer from @mskcancercenter.bsky.social
š Open access: sciexplor.com/exo/articles...
#Ferroptosis #CellDeath #RedoxBiology
